Literature DB >> 2958707

Predictors of patients' experience of pain in EMG.

S Khoshbin1, M Hallett, R Lunbeck.   

Abstract

The important features that predict the amount of pain experienced by patients with low back pain who undergo needle electromyography were the patients' assessment of their own pain, their trait-anxiety levels, and female sex. Although it does not influence EMG pain, information about the test will decrease the anxiety of patients coming for testing.

Entities:  

Mesh：

Year:  1987        PMID： 2958707     DOI： 10.1002/mus.880100708

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


  5 in total

1.  Expected and Experienced Pain Levels in Electromyography.

Authors:  Pınar Yalinay Dikmen; Elif Ilgaz Aydinlar; Geysu Karlikaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

2.  Patient perception of pain versus observed pain behavior during a standardized electrodiagnostic test.

Authors:  Josh Verson; Andrew J Haig; Danielle Sandella; Karen S J Yamakawa; Zachary London; Christy Tomkins-Lane
Journal:  Muscle Nerve       Date:  2014-12-16       Impact factor: 3.217

3.  Factors influencing aversion to specific electrodiagnostic studies.

Authors:  Nivedita U Jerath; Scott B Strader; Chandan G Reddy; Andrea Swenson; Jun Kimura; Edward Aul
Journal:  Brain Behav       Date:  2014-07-22       Impact factor: 2.708

4.  Assessment of Pain During Nerve Conduction Studies in Patients With Carpal Tunnel Syndrome.

Authors:  Toru Sasaki; Akimoto Nimura; Tomoyuki Kuroiwa; Takafumi Koyama; Atsushi Okawa; Koji Fujita
Journal:  J Hand Surg Glob Online       Date:  2022-01-05

5.  The provision of written information and its effect on levels of pain and anxiety during electrodiagnostic studies: A randomised controlled trial.

Authors:  Yan Ling Lai; Annemarie Van Heuven; Adeniyi Borire; Tejaswi Kandula; James G Colebatch; Arun V Krishnan; William Huynh
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.